Kelyniam Global, Inc. (KLYG) Research

Kelyniam Global, Inc. operates as a medical device manufacturer, providing specialized solutions for patients. The company creates custom prosthetics using computer-aided design (CAD) and manufacturing (CAM) processes, employing advanced medical-grade polymers. Additionally, Kelyniam develops, produces, and supplies specific cranial and craniofacial fixation screws, crucial for the reconstruction of skull and facial structures. Its clientele encompasses health systems, hospitals, sales representatives, surgeons, insurance providers (payors), and individual patients. Established in 2005, the company was originally named Ketner Global Investments, Inc., rebranding to Kelyniam Global, Inc. in December 2007. Kelyniam Global is based in Collinsville, Connecticut.

Market snapshot

Symbol
KLYG
Price
$0.14
Day change
0.00%
Market cap
$1.8M
P/E ratio
-215.12x
52-week range
0.05-0.3
Sector
Healthcare
Industry
Medical - Devices

Peer companies

  • Algernon Pharmaceuticals Inc. (AGNPF)
  • Caduceus Software Systems Corp. (CSOC)
  • Genix Pharmaceuticals Corporation (GENPF)
  • Imagion Biosystems Limited (IBXXF)
  • Indo Global Exchange(s) PTE, Ltd. (IGEX)
  • Medical Supply International USA, Inc. (MSIU)
  • Restart Life Sciences Corp. (NMLSF)
  • Nu-Med Plus, Inc. (NUMD)

Recent insider activity

  • Ketner James — J-Other (35000 shares) on 2008-06-25
  • Ketner James — J-Other (500000 shares) on 2008-06-25
  • Ketner James — P-Purchase (4800 shares) on 2008-04-07
  • Ketner James — P-Purchase (4800 shares) on 2008-04-07
  • Ketner James — J-Other (200000 shares) on 2008-04-03

Open Kelyniam Global, Inc. (KLYG) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.